← All organizations

Presidio Pharmaceuticals

For profit

Also known as: Presidio Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 1, 2014

Acquired by BioCryst on Oct 18, 2012

Timeline

2000s

Jun 1, 2006
Presidio Pharmaceuticals— Founded

2010s

Oct 18, 2012
BioCryst— Acquired By

Drugs by trial phase (9 distinct, 7 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

NCT02258321Study directorPhase 1Oct 1, 2014
NCT02258321Lead sponsorPhase 1Oct 1, 2014
NCT01979484Study directorPhase 1Oct 1, 2013
NCT01979484Lead sponsorPhase 1Oct 1, 2013
NCT01928147Lead sponsorPhase 1Aug 1, 2013
NCT01928147Study directorPhase 1Aug 1, 2013
NCT01859962Study directorPhase 2May 1, 2013
NCT01859962Lead sponsorPhase 2May 1, 2013
NCT01786382Lead sponsorPhase 1Feb 1, 2013
NCT01448200Study directorPhase 1Oct 1, 2011
NCT01448200Lead sponsorPhase 1Oct 1, 2011
NCT01247194Study directorPhase 1Oct 1, 2010
NCT01247194Lead sponsorPhase 1Oct 1, 2010

Details

Founded: San Francisco, CA, US Jun 1, 2006
Last known activity: Oct 1, 2014